Refiye Yanardag

Dr. Refiye Yanardag

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RYRefiye Yanardag
Refiye Yanardag
TDTulay Bal Demirci
Tulay Bal Demirci
BUBahri Ulküseven
Bahri Ulküseven
SBSema Bolkent
Sema Bolkent
STSevim Tunali
Sevim Tunali
SBSehnaz Bolkent
Sehnaz Bolkent

11 September 2013 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Open access
PDF file
BSBahar Bilgin Sokmen
Bahar Bilgin Sokmen
SUSerpil Ugras
Serpil Ugras
HSHasan Yucel Sarikaya
Hasan Yucel Sarikaya
HUHalil Ibrahim Ugras
Halil Ibrahim Ugras
RYRefiye Yanardag
Refiye Yanardag
Some series of arylidene barbiturates and thiobarbiturates were evaluated for their antibacterial, antioxidant, and urease inhibition activities. The arylidene barbiturates and thiobarbiturates were tested for antimicrobial activity using the agar well diffusion technique against 13 bacteria. The synthesized compounds (1a–g) were screened for antiurease and antioxidant activities. The results showed that the synthesized compounds (1a–g) had effective antiurease, antioxidant, and antibacterial activities.

1 March 2005 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
RYRefiye Yanardag
Refiye Yanardag
OOO Ozsoy-Sacan
O Ozsoy-Sacan
SBS Bolkent
S Bolkent
HOH Orak
H Orak
OKO Karabulut-Bulan
O Karabulut-Bulan
Metformin is a biguanide derivate used as an oral hypoglycaemic drug in diabetics. The aim of this study was to examine the histological and biochemical effects of metformin in streptozotocin (STZ)-treated rats. The animals were rendered diabetic by intraperitoneal injection of 65 mg/kg STZ. Fourteen days later, metformin was given at 25 mg/kg by gavage, daily for 28 days, to STZdiabetic rats and a control group. In the STZ-diabetic group, some degenerative changes were observed by light microscopic examination. But the degenerative changes were decreased in the STZ-diabetic group given metformin. In the STZ-diabetic group, blood glucose levels, serum alanine and aspartate transaminase (ALT and AST) activities, total lipid levels, and sodium and potassium levels increased, while body weight, serum magnesium levels and liver glutathione (GSH) levels decreased. In the STZ-diabetic group given metformin, blood glucose levels, serum ALT and AST activities, total lipid, and sodium and potassium levels decreased, and liver GSH and serum magnesium levels increased. As a result of all the morphological and biochemical findings obtained, it was concluded that metformin has a protective effect against the hepatotoxicity produced by STZ diabetes.

27 January 2016 in BioMetals
Verified
Journal Article
Closed access
PDF file
OSOzlem SACAN
Ozlem SACAN
ITIsmet Burcu Turkyilmaz
Ismet Burcu Turkyilmaz
BBBertan Boran Bayrak
Bertan Boran Bayrak
OMOzgur Mutlu
Ozgur Mutlu
NANuriye Akev
Nuriye Akev
RYRefiye Yanardag
Refiye Yanardag

26 August 2020 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
FOFusun Oztay
Fusun Oztay
STSevim Tunali
Sevim Tunali
OKOzgecan Kayalar
Ozgecan Kayalar
RYRefiye Yanardag
Refiye Yanardag

11 March 2006 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
RYRefiye Yanardag
Refiye Yanardag
STSevim Tunali
Sevim Tunali